about
Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategiesOncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial RespirationCancer stem cells and the tumor microenvironment: interplay in tumor heterogeneityTracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations.Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive systemMetabolic control of cancer cell stemness: Lessons from iPS cellsMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseEpithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?OVCAR-3 spheroid-derived cells display distinct metabolic profilesRheb phosphorylation is involved in p38-regulated/activated protein kinase-mediated tumor suppression in liver cancer.Activation of the methylation cycle in cells reprogrammed into a stem cell-like state.Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions.Accelerated geroncogenesis in hereditary breast-ovarian cancer syndromeA novel method to limit breast cancer stem cells in states of quiescence, proliferation or differentiation: Use of gel stress in combination with stem cell growth factorsIntegrated omics-analysis reveals Wnt-mediated NAD+ metabolic reprogramming in cancer stem-like cells.Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer.The metabolic landscape of cancer stem cells.Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches.Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype.Oncometabolic Nuclear Reprogramming of Cancer Stemness.Spotlight on the relevance of mtDNA in cancer.A link between cold environment and cancer.Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs).Senescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer.Nuclear reprogramming of cancer stem cells: Corrupting the epigenetic code of cell identity with oncometabolitesMetformin targets histone acetylation in cancer-prone epithelial cells.Metabostemness: Metaboloepigenetic reprogramming of cancer stem-cell functions.Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity.Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment.Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.Fatty acid synthase (FASN) as a therapeutic target in breast cancer.Targeted SERS nanosensors measure physicochemical gradients and free energy changes in live 3D tumor spheroids.Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model.Cancer metabolism: New insights into classic characteristics.Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
P2860
Q26750380-B8101ACB-9CA3-4046-A134-3DCF56DBB35BQ26766876-52FCACDD-E1FC-455E-8886-6E0F3FED8C2CQ26796292-47E0F943-0D1A-423A-A9C3-27B91A24767DQ27335464-713C22F4-B6F4-4580-B8A3-ED5EE97DE554Q28079367-201ED5B0-441C-4513-B98D-1A0D79233F54Q28081608-F29E1388-DBC2-4DFC-A588-737CA90139D1Q28394732-46326B7F-490F-4F35-97C9-08F32001A511Q33869760-E1D53CC3-8C3B-47A7-BEB1-BF32404078F7Q35091823-F7EF3697-0F23-45F7-B751-E04B9ECCBB49Q35944443-DBF931CB-641E-4410-B37B-6A570D9537A0Q36527529-98ADDE66-3C14-407D-92C2-48F9BE830B86Q36583430-85578672-F665-4CD3-9A1C-8FE54521F209Q37022075-A3494DF1-87EC-4453-971C-E20F42F82016Q37106464-832455D6-32C4-46CC-B237-B28CF6633AAFQ37565536-55F1C70C-3568-46CF-B309-B2034B78EDE5Q37687587-B0DABCBF-9E73-4314-91C1-45C490132CD6Q38580323-61ED1D6D-769C-4CF5-B067-C591A30BFA57Q38704618-60E1C292-0070-4120-B78D-D086FFE43E21Q38874166-D3063A0F-E450-43FA-B85E-21CC694B43D5Q38951334-228B7AAD-6C69-4339-B2C2-251796E8301FQ38990083-5FA714CE-6A1A-4DC3-A176-89C5CB9635B2Q41304645-1042A667-63B8-4FEF-82E7-F54B44553551Q41911837-1F01AAB2-7D85-4633-A434-2080C205C68DQ42121084-696B773F-D103-4469-856A-A580B34B5558Q42351264-F4C9498F-8A63-4917-9C38-CF720E92D9A9Q42983569-02D64F69-A36B-4890-AA42-7E0A023B7EFEQ43116430-291B4D78-585F-4FEC-83CD-8FD880C70A87Q47110103-24C13FCD-2DFA-460B-8676-C349CE05C87BQ47390152-92CF79C0-655C-4497-ACEC-AEFD9E04455DQ49244460-7BE97D5E-2E93-48F1-9A80-E246DBB76750Q50044384-D9E7CB9D-DBCF-428C-9760-2B582639C9E0Q51142915-2852A413-766A-40D0-9D3A-E0D2740732ABQ51556720-DB5F9413-143E-4DFA-BF11-7B7A21D4ACCFQ53697366-F81A4FC9-63B1-4862-BB0D-8142CD496A9DQ55254924-7D321B45-C1E8-477E-BAAC-82348187B196
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Metabostemness: a new cancer hallmark.
@en
type
label
Metabostemness: a new cancer hallmark.
@en
prefLabel
Metabostemness: a new cancer hallmark.
@en
P2860
P356
P1476
Metabostemness: a new cancer hallmark
@en
P2093
Javier A Menendez
Tomás Alarcón
P2860
P356
10.3389/FONC.2014.00262
P577
2014-09-29T00:00:00Z